[HTML][HTML] Preclinical evaluation of the association of the cyclin-dependent kinase 4/6 inhibitor, ribociclib, and cetuximab in squamous cell carcinoma of the head and …
G van Caloen, S Schmitz, C Van Marcke, X Caignet… - Cancers, 2021 - mdpi.com
Simple Summary We previously showed that ribociclib induces cell cycle arrest in some
human papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck …
human papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck …
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck
G van Caloen, S Schmitz, C van Marcke… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) overexpression is observed in 90% of human
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
G van Caloen, S Schmitz, C van Marcke, X Caignet… - Cancers, 2021 - dial.uclouvain.be
Epidermal growth factor receptor (EGFR) overexpression is observed in 90% of human
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
[HTML][HTML] Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head …
G van Caloen, S Schmitz, C van Marcke, X Caignet… - Cancers, 2021 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) overexpression is observed in 90% of human
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
[引用][C] Preclinical evaluation of the association of the cyclin-dependent kinase 4/6 inhibitor, ribociclib, and cetuximab in squamous cell carcinoma of the head and neck
G van Caloen, S Schmitz, C Van Marcke… - Cancers …, 2021 - difusion.ulb.ac.be
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
G van Caloen, S Schmitz, C van Marcke… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: We previously showed that ribociclib induces cell cycle arrest in
some human papillomavirus (HPV)-negative squamous cell carcinomas of the head and …
some human papillomavirus (HPV)-negative squamous cell carcinomas of the head and …
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
G van Caloen, S Schmitz, C van Marcke, X Caignet… - Cancers, 2021 - europepmc.org
Epidermal growth factor receptor (EGFR) overexpression is observed in 90% of human
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck.
G van Caloen, S Schmitz, C van Marcke, X Caignet… - Cancers, 2021 - europepmc.org
Epidermal growth factor receptor (EGFR) overexpression is observed in 90% of human
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …
papillomavirus (HPV)-negative squamous cell carcinomas of the head and neck (SCCHN) …